Traliant Announces Family and Medical Leave Act (FMLA) Training

[ad_1]

With a lot of employees dealing with new work-family issues, FMLA training should be a priority for managers,” said Mike Pallatta, Traliant CEO and Co-Founder.

Traliant, an innovator in online sexual harassment training and diversity training, today announced a new training course for managers on the Family and Medical Leave Act (FMLA), and the new Families First Coronavirus Response Act (FFCRA), which expands the FMLA with paid sick and family leave provisions related to COVID-19.

For more information, please visit: FMLA Training

“With a lot of employees dealing with new work-family issues, FMLA training should be a priority for managers,” said Mike Pallatta, Traliant CEO and Co-Founder. “Our new FMLA course focuses on managers’ responsibilities to properly handle requests for time off — including reasons related to COVID-19 — and help their organizations comply with the FMLA, the FFCRA and other leave laws.”

Designed in a modern, interactive format, Traliant’s Family and Medical Leave Act provides an overview of the FMLA and the FFCRA and the process of complying with leave requests. Managers learn how to recognize and respond promptly to employee leave requests, and avoid retaliation or interference. The 25-minute course features a video host, viewer email questions and eLearning interactions to boost engagement and reinforce key concepts. A certificate of completion is included.

About Traliant

Traliant was founded by industry veterans from some of the world’s most successful compliance training companies to meet the challenge of transforming compliance training from boring to brilliant. Backed by Martinson Ventures, Traliant delivers award-winning, bite-sized compliance training on an eLearning platform that enables fast and easy customization. Courses are available on numerous workplace topics including Diversity Training and Sensitivity Training. For more information, visit: http://www.traliant.com.

Share article on social media or email:

[ad_2]

Leave a Reply